AFT Pharmaceuticals (ASX:AFP) EV-to-Revenue : 1.40 (As of Jun. 24, 2025)

AFT Pharmaceuticals EV-to-Revenue Chart

AFT Pharmaceuticals Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
EV-to-Revenue		Get a 7-Day Free Trial					4.92	3.16	2.54	1.80	1.46

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial														2.54	-	1.80	-	1.46

Competitive Comparison of AFT Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's EV-to-Revenue falls into.

AFT Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

AFT Pharmaceuticals's EV-to-Revenue for today is calculated as:

AFT Pharmaceuticals's current Enterprise Value is A$261.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AFT Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was A$187.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals  (ASX:AFP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

AFT Pharmaceuticals's PS Ratiofor today is calculated as:

AFT Pharmaceuticals's share price for today is A$2.26.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Mar. 2025 was A$1.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals Business Description